How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.

NCT06495021 | Recruiting

• 1 other identifier: 2024-0453
• Study Type: interventional
• Target: 68
• Locations: 1 country
• Sites: 1

Brief Summary

This study is to see Osteopathic Manipulative Therapy, or OMT, can aid in treating patients being seen for respiratory illness and associated symptoms. The hypothesis is that the addition of OMT therapy, alongside other standard care (such as a medication), can help lessen patient symptoms sooner than just other treatment alone, and the duration of the condition will shorten as well.

Conditions

Pneumonia; Sinusitis; Bronchitis; Respiratory Disease; Respiratory Tract Infections

Keywords

Osteopathic Manual Therapy; Respiratory Illness; OMT

Outcome Measures

Primary Outcomes (1)

• To address the magnitude in which lymphatic pump OMT improves respiratory illness symptom severity and overall sickness duration when combined with standard care treatment.

  Survey given to patients will provide feedback to capture their symptom severity at the time of diagnosis and 5 days post-diagnosis

  Through study completion of up to one year.

Study Arms (2)

Control

NO INTERVENTION

Patients in the control group will receive normal standard care, including any prescriptions, follow-up instructions, etc., as given by the provider to help treat their condition.

Treatment

EXPERIMENTAL

Patients will receive lymphatic pump OMT therapy in addition to other standard care (similar to the control patients, this would be a medication, follow-up instructions, etc.)

Procedure: Lymphatic Pump Osteopathic Manipulative Therapy

Interventions

Lymphatic Pump Osteopathic Manipulative Therapy PROCEDURE

OMT is a series of manual pressure and physical stimulation among various parts of the body to stimulate fluid movement and immune response in patients with various symptoms and disease. This may help with conditions such as edema, clearance of infections, facilitate healing and circulation, and bolster the immune response. Specifically, the lymphatic pump type of OMT targets the head, neck, thoracic region, lumbar and sacral regions, pelvis, arms, legs, and abdomen.

Also known as: Lymphatic Pump OMT

Treatment

Eligibility Criteria

• Age: 65 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• Patients being seen for respiratory illness symptoms at Geisinger 65-Forward Buckhorn, PA clinic for care.
• Patients age of 65-100
• New diagnosis of upper respiratory illness, sinusitis, bronchitis, or pneumonia during outpatient visit.

You may not qualify if:

• Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities.
• Patients actively receiving any type of cancer treatment
• Patients with active or previously diagnosed liver disease.

Sponsors & Collaborators

• Geisinger Clinic: lead

Study Sites (1)

Geisinger 65-Forward, Buckhorn

Bloomsburg, Pennsylvania, 17815, United States

RECRUITING

Related Publications (9)

• Creasy C, Schander A, Orlowski A, Hodge LM. Thoracic and abdominal lymphatic pump techniques inhibit the growth of S. pneumoniae bacteria in the lungs of rats. Lymphat Res Biol. 2013 Sep;11(3):183-6. doi: 10.1089/lrb.2013.0007. Epub 2013 Sep 11.

  PMID: 24024572 BACKGROUND

• Hodge LM, Creasy C, Carter K, Orlowski A, Schander A, King HH. Lymphatic pump treatment as an adjunct to antibiotics for pneumonia in a rat model. J Am Osteopath Assoc. 2015 May;115(5):306-16. doi: 10.7556/jaoa.2015.061.

  PMID: 25938525 BACKGROUND

• Knott EM, Tune JD, Stoll ST, Downey HF. Increased lymphatic flow in the thoracic duct during manipulative intervention. J Am Osteopath Assoc. 2005 Oct;105(10):447-56.

  PMID: 16314677 BACKGROUND

• Saggio G, Docimo S, Pilc J, Norton J, Gilliar W. Impact of osteopathic manipulative treatment on secretory immunoglobulin a levels in a stressed population. J Am Osteopath Assoc. 2011 Mar;111(3):143-7.

  PMID: 21464262 BACKGROUND

• Noll DR, Degenhardt BF, Fossum C, Hensel K. Clinical and research protocol for osteopathic manipulative treatment of elderly patients with pneumonia. J Am Osteopath Assoc. 2008 Sep;108(9):508-16.

  PMID: 18806080 BACKGROUND

• Noll DR, Degenhardt BF, Johnson JC. Multicenter Osteopathic Pneumonia Study in the Elderly: Subgroup Analysis on Hospital Length of Stay, Ventilator-Dependent Respiratory Failure Rate, and In-hospital Mortality Rate. J Am Osteopath Assoc. 2016 Sep 1;116(9):574-87. doi: 10.7556/jaoa.2016.117.

  PMID: 27571294 BACKGROUND

• Yao S, Hassani J, Gagne M, George G, Gilliar W. Osteopathic manipulative treatment as a useful adjunctive tool for pneumonia. J Vis Exp. 2014 May 6;(87):50687. doi: 10.3791/50687.

  PMID: 24836893 BACKGROUND

• Noll DR. The short-term effect of a lymphatic pump protocol on blood cell counts in nursing home residents with limited mobility: a pilot study. J Am Osteopath Assoc. 2013 Jul;113(7):520-8. doi: 10.7556/jaoa.2013.003.

  PMID: 23843375 BACKGROUND

• Becker AD. Osteopathic treatment of the common cold. 1937. J Am Osteopath Assoc. 2001 Aug;101(8):461-3. No abstract available.

  PMID: 11534526 BACKGROUND

MeSH Terms

Conditions

Pneumonia; Sinusitis; Bronchitis; Respiration Disorders; Respiratory Tract Infections

Condition Hierarchy (Ancestors)

Infections; Lung Diseases; Respiratory Tract Diseases; Paranasal Sinus Diseases; Nose Diseases; Otorhinolaryngologic Diseases; Bronchial Diseases; Lung Diseases, Obstructive

Study Officials

• Margaret Moore, DO

  Physician

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Margaret Moore, DO

CONTACT

(570) 416-5435; Mmoore9@geisinger.edu

Andrew Ackerman, MS

CONTACT

(570) 214-4215; aackerman1@geisinger.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Patients will be randomized into a control group and treatment group for their duration of the study upon informed consent. Control patients will not receive lymphatic pump OMT, while treatment patients will receive lymphatic pump therapy.

Study Record Dates

• First Submitted: July 3, 2024
• First Posted: July 10, 2024
• Study Start: December 31, 2024
• Primary Completion (Estimated): June 1, 2026
• Study Completion (Estimated): June 1, 2026
• Last Updated: July 8, 2025

Record last verified: 2025-07

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)